Literature DB >> 27329285

The PARP family: insights into functional aspects of poly (ADP-ribose) polymerase-1 in cell growth and survival.

T Jubin1, A Kadam1, M Jariwala1, S Bhatt1, S Sutariya1, A R Gani1, S Gautam2, R Begum1.   

Abstract

PARP family members can be found spread across all domains and continue to be essential molecules from lower to higher eukaryotes. Poly (ADP-ribose) polymerase 1 (PARP-1), newly termed ADP-ribosyltransferase D-type 1 (ARTD1), is a ubiquitously expressed ADP-ribosyltransferase (ART) enzyme involved in key cellular processes such as DNA repair and cell death. This review assesses current developments in PARP-1 biology and activation signals for PARP-1, other than conventional DNA damage activation. Moreover, many essential functions of PARP-1 still remain elusive. PARP-1 is found to be involved in a myriad of cellular events via conservation of genomic integrity, chromatin dynamics and transcriptional regulation. This article briefly focuses on its other equally important overlooked functions during growth, metabolic regulation, spermatogenesis, embryogenesis, epigenetics and differentiation. Understanding the role of PARP-1, its multidimensional regulatory mechanisms in the cell and its dysregulation resulting in diseased states, will help in harnessing its true therapeutic potential.
© 2016 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27329285      PMCID: PMC6496725          DOI: 10.1111/cpr.12268

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  177 in total

1.  PARP-3 is a mono-ADP-ribosylase that activates PARP-1 in the absence of DNA.

Authors:  Olga Loseva; Ann-Sofie Jemth; Helen E Bryant; Herwig Schüler; Lari Lehtiö; Tobias Karlberg; Thomas Helleday
Journal:  J Biol Chem       Date:  2010-01-11       Impact factor: 5.157

Review 2.  Poly(ADP-ribosyl)ation reactions in the regulation of nuclear functions.

Authors:  D D'Amours; S Desnoyers; I D'Silva; G G Poirier
Journal:  Biochem J       Date:  1999-09-01       Impact factor: 3.857

3.  Poly(ADP-ribose) polymerase-dependent energy depletion occurs through inhibition of glycolysis.

Authors:  Shaida A Andrabi; George K E Umanah; Calvin Chang; Daniel A Stevens; Senthilkumar S Karuppagounder; Jean-Philippe Gagné; Guy G Poirier; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-01       Impact factor: 11.205

Review 4.  Poly(ADP-ribose): novel functions for an old molecule.

Authors:  Valérie Schreiber; Françoise Dantzer; Jean-Christophe Ame; Gilbert de Murcia
Journal:  Nat Rev Mol Cell Biol       Date:  2006-07       Impact factor: 94.444

Review 5.  Molecular and biochemical features of poly (ADP-ribose) metabolism.

Authors:  D Lautier; J Lagueux; J Thibodeau; L Ménard; G G Poirier
Journal:  Mol Cell Biochem       Date:  1993-05-26       Impact factor: 3.396

6.  Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase.

Authors:  F Moroni; A Cozzi; A Chiarugi; L Formentini; E Camaioni; D E Pellegrini-Giampietro; Y Chen; S Liang; M M Zaleska; C Gonzales; A Wood; R Pellicciari
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

7.  Cell death and autophagy under oxidative stress: roles of poly(ADP-Ribose) polymerases and Ca(2+).

Authors:  Philippe Wyrsch; Christian Blenn; Jessica Bader; Felix R Althaus
Journal:  Mol Cell Biol       Date:  2012-07-02       Impact factor: 4.272

Review 8.  CCCTC-binding factor meets poly(ADP-ribose) polymerase-1.

Authors:  Paola Caiafa; Jordanka Zlatanova
Journal:  J Cell Physiol       Date:  2009-05       Impact factor: 6.384

9.  DNA-dependent SUMO modification of PARP-1.

Authors:  Nicola Zilio; Chris T Williamson; Sebastian Eustermann; Rajvee Shah; Stephen C West; David Neuhaus; Helle D Ulrich
Journal:  DNA Repair (Amst)       Date:  2013-07-18

10.  Distribution of protein poly(ADP-ribosyl)ation systems across all domains of life.

Authors:  Dragutin Perina; Andreja Mikoč; Josip Ahel; Helena Ćetković; Roko Žaja; Ivan Ahel
Journal:  DNA Repair (Amst)       Date:  2014-05-25
View more
  33 in total

1.  Fluorine-18 labeled poly (ADP-ribose) polymerase1 inhibitor as a potential alternative to 2-deoxy-2-[18F]fluoro-d-glucose positron emission tomography in oral cancer imaging.

Authors:  Paula Demétrio de Souza França; Sheryl Roberts; Susanne Kossatz; Navjot Guru; Christian Mason; Daniella Karassawa Zanoni; Marcio Abrahão; Heiko Schöder; Ian Ganly; Snehal G Patel; Thomas Reiner
Journal:  Nucl Med Biol       Date:  2020-01-23       Impact factor: 2.408

Review 2.  Modulating NAD+ metabolism, from bench to bedside.

Authors:  Elena Katsyuba; Johan Auwerx
Journal:  EMBO J       Date:  2017-08-07       Impact factor: 11.598

3.  Parent-Metabolite Pharmacokinetic Modeling and Pharmacodynamics of Veliparib (ABT-888), a PARP Inhibitor, in Patients With BRCA 1/2-Mutated Cancer or PARP-Sensitive Tumor Types.

Authors:  Jing Niu; Christie Scheuerell; Shailly Mehrotra; Sharon Karan; Shannon Puhalla; Brian F Kiesel; Jiuping Ji; Edward Chu; Mathangi Gopalakrishnan; Vijay Ivaturi; Jogarao Gobburu; Jan H Beumer
Journal:  J Clin Pharmacol       Date:  2017-04-07       Impact factor: 3.126

Review 4.  DNA Repair: Translation to the Clinic.

Authors:  E V Minten; D S Yu
Journal:  Clin Oncol (R Coll Radiol)       Date:  2019-03-12       Impact factor: 4.126

5.  Cancer treatment-induced NAD+ depletion in premature senescence and late cardiovascular complications.

Authors:  Priyanka Banerjee; Elizabeth A Olmsted-Davis; Anita Deswal; Minh Th Nguyen; Efstratios Koutroumpakis; Nicholas L Palaskas; Steven H Lin; Sivareddy Kotla; Cielito Reyes-Gibby; Sai-Ching J Yeung; Syed Wamique Yusuf; Momoko Yoshimoto; Michihiro Kobayashi; Bing Yu; Keri Schadler; Joerg Herrmann; John P Cooke; Abhishek Jain; Eduardo Chini; Nhat-Tu Le; Jun-Ichi Abe
Journal:  J Cardiovasc Aging       Date:  2022-04-29

6.  Colchicine-Binding Site Agent CH-2-77 as a Potent Tubulin Inhibitor Suppressing Triple-Negative Breast Cancer.

Authors:  Shanshan Deng; Raisa I Krutilina; Kelli L Hartman; Hao Chen; Deanna N Parke; Rui Wang; Foyez Mahmud; Dejian Ma; Pradeep B Lukka; Bernd Meibohm; Tiffany N Seagroves; Duane D Miller; Wei Li
Journal:  Mol Cancer Ther       Date:  2022-07-05       Impact factor: 6.009

7.  A one-pot radiosynthesis of [18 F]PARPi.

Authors:  Thomas C Wilson; Nagavarakishore Pillarsetty; Thomas Reiner
Journal:  J Labelled Comp Radiopharm       Date:  2020-06-16       Impact factor: 1.921

8.  Synthesis and Evaluation of a Mitochondria-Targeting Poly(ADP-ribose) Polymerase-1 Inhibitor.

Authors:  Tanja Krainz; Andrew M Lamade; Lina Du; Taber S Maskrey; Michael J Calderon; Simon C Watkins; Michael W Epperly; Joel S Greenberger; Hülya Bayır; Peter Wipf; Robert S B Clark
Journal:  ACS Chem Biol       Date:  2018-09-14       Impact factor: 5.100

9.  Oxidatively modified low-density lipoproteins are potential mediators of proteasome inhibitor resistance in multiple myeloma.

Authors:  Srikanth R Polusani; Valerie Cortez; Javier Esparza; Huynh Nga Nguyen; Hongxin Fan; Gopalrao V N Velagaleti; Matthew J Butler; Marsha C Kinney; Babatunde O Oyajobi; Samy L Habib; Reto Asmis; Edward A Medina
Journal:  Int J Cancer       Date:  2021-03-08       Impact factor: 7.316

10.  Characterization of PARP6 Function in Knockout Mice and Patients with Developmental Delay.

Authors:  Anke Vermehren-Schmaedick; Jeffrey Y Huang; Madison Levinson; Matthew B Pomaville; Sarah Reed; Gary A Bellus; Fred Gilbert; Boris Keren; Delphine Heron; Damien Haye; Christine Janello; Christine Makowski; Katharina Danhauser; Lev M Fedorov; Tobias B Haack; Kevin M Wright; Michael S Cohen
Journal:  Cells       Date:  2021-05-22       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.